A recent systematic review and network meta-analysis assessed the cardiovascular effects of attention-deficit/hyperactivity disorder (ADHD) medications across children, adolescents, and adults with ADHD. The authors conclude that while changes in cardiovascular parameters were generally small, prescribers should routinely monitor patients during treatment.